Schonfeld Strategic Advisors’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.3K Sell
29,115
-21,089
-42% -$19.4K ﹤0.01% 2073
2025
Q4
$110K Buy
+50,204
New +$80.8K ﹤0.01% 1806

Other funds holding GUTS

Schonfeld Strategic Advisors's GUTS Position: Q1 2026 in Review

Schonfeld Strategic Advisors reduced its Fractyl Health (GUTS) stake by 42% in Q1 2026, selling an estimated $19.4K and leaving 29,115 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Schonfeld Strategic Advisors first reported a position in GUTS in Q4 2025 and has held it in 2 quarters since. The position peaked at $110K in Q4 2025. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

  • Schonfeld Strategic Advisors held 29,115 shares of Fractyl Health worth $13.3K as of Q1 2026.
  • Schonfeld Strategic Advisors sold 21,089 Fractyl Health shares in Q1 2026, an estimated $19.4K.
  • Fractyl Health made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q1 2026, its #2073 holding.
  • Schonfeld Strategic Advisors first reported a position in Fractyl Health in Q4 2025 and has held it in 2 quarters since.
  • Schonfeld Strategic Advisors's Fractyl Health position peaked at $110K in Q4 2025.
  • 83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.